postremission therapy

postremission therapy

Oncology Chemotherapy to kill CA cells surviving remission-inducing therapy. See Remission.
References in periodicals archive ?
A long-term follow-up of the Group for Research on Adult Acute Lymphoblastic Leukemia Philadelphia- positive-2003 trial described the outcomes of 45 patients whose postremission therapy was partly decided by MRD results.
showed that the FLT3-ITD mRNA level has a high prognostic impact in NPM1-mutated AML-NK, and that it contributes to relapse risk stratification and might help to guide postremission therapy in NPM1-mutated AML (29).
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study Blood 2000;96:4075-4083.
23) Marcucci et al (10) reported that 50% of patients with CBF AML have long-term survival when repetitive cycles of high-dose cytarabine are used as postremission therapy.